Cosmo Pharmaceuticals (CMOPF) News Today → The Long-Awaited End of America Update (From Stansberry Research) (Ad) Free CMOPF Stock Alerts C$80.00 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023finance.yahoo.com - April 29 at 10:09 PMDespite concern about older adults living alone, these seniors prefer the solo life: 'I love not having to answer to anyone else'msn.com - April 29 at 5:08 PMCosmo Pharmaceuticals (OTC:CMOPF) Stock Price Up 4.4%americanbankingnews.com - April 27 at 2:58 AMCosmo Announces Leadership Changesfinance.yahoo.com - April 25 at 3:31 AMQ4 2023 Paysign Inc Earnings Callfinance.yahoo.com - March 28 at 3:22 PMBullish: Analysts Just Made A Massive Upgrade To Their Cosmo Pharmaceuticals N.V. (VTX:COPN) Forecastsfinance.yahoo.com - March 28 at 5:22 AMCosmo Pharmaceuticals N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Nowfinance.yahoo.com - March 23 at 5:24 AMCosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results - Record Guidance for 2024 - Doubles Dividend to 2.00 per Sharefinance.yahoo.com - March 20 at 5:12 AMCosmo Pharmaceuticals Announces Approval of Winlevi(R) in Australiafinance.yahoo.com - March 19 at 3:56 AMSay Hi to the Cosmo Trend Report: A Comprehensive Look at All the Things You’re Gonna Want to Wear This Springmsn.com - March 15 at 10:07 AMCosmo Pharmaceuticals (VTX:COPN) shareholders have endured a 18% loss from investing in the stock three years agofinance.yahoo.com - March 13 at 9:46 AMGibson to open huge guitar store in West End on Saturdaymsn.com - February 23 at 9:11 PMPupils unwell after school lab chemical spillau.news.yahoo.com - February 22 at 7:48 PMCosmo Pharmaceuticals N.V.wsj.com - February 20 at 8:56 AMCosmoprof North America Miami Celebrates Its Inaugural Edition with Overwhelming Success with over 19,000 Visitsmarkets.businessinsider.com - February 1 at 4:28 PMInvitation to Cosmo's Investor Day and Full-Year 2023 Webcast - Zurich, 20 March 2024finance.yahoo.com - January 25 at 4:45 AMBrokers Are Upgrading Their Views On Cosmo Pharmaceuticals N.V. (VTX:COPN) With These New Forecastsfinance.yahoo.com - January 5 at 3:51 AMCosmo Pharmaceuticals N.V. (VTX:COPN) Stocks Shoot Up 37% But Its P/S Still Looks Reasonablefinance.yahoo.com - December 18 at 9:37 AMMarket Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues Pushing Shares 37% Higherfinance.yahoo.com - December 18 at 9:37 AMCosmo Pharmaceuticals NV CMOPFmorningstar.com - November 23 at 3:19 PMCosmo Pharmaceuticals N.V.'s (VTX:COPN) top owners are private companies with 47% stake, while 35% is held by individual investorsfinance.yahoo.com - November 23 at 10:19 AMCosmo Pharmaceuticals (VTX:COPN) shareholders have endured a 68% loss from investing in the stock five years agofinance.yahoo.com - October 5 at 9:35 AMCosmo, Glenmark Sign Distribution And License Agreements For Winlevi In Europe, South Africamsn.com - September 27 at 8:34 AMCosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africabenzinga.com - September 27 at 8:34 AMCOSMO Pharmaceuticals SA (COPN)investing.com - September 16 at 1:41 AMCosmo Pharmaceuticals N.V.'s (VTX:COPN) P/E Still Appears To Be Reasonablefinance.yahoo.com - September 14 at 1:03 PMCosmo Pharmaceuticals (VTX:COPN) shareholders have endured a 58% loss from investing in the stock five years agofinance.yahoo.com - September 14 at 1:03 PMCosmo Pharmaceuticals N.V.'s (VTX:COPN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?finance.yahoo.com - September 14 at 1:03 PMCosmo Pharmaceuticals N.V. (VTX:COPN) Is About To Go Ex-Dividend, And It Pays A 2.0% Yieldfinance.yahoo.com - September 14 at 1:03 PMWhile individual investors own 36% of Cosmo Pharmaceuticals N.V. (VTX:COPN), private companies are its largest shareholders with 47% ownershipfinance.yahoo.com - September 14 at 1:03 PMCosmo Pharmaceuticals First Half 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - September 14 at 1:03 PM Get Cosmo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CMOPF and its competitors with MarketBeat's FREE daily newsletter. Email Address The Long-Awaited End of America Update (Ad)A 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. CMOPF Media Mentions By Week CMOPF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMOPF News Sentiment▼0.910.32▲Average Medical News Sentiment CMOPF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMOPF Articles This Week▼30▲CMOPF Articles Average Week Get Cosmo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CMOPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AstraZeneca News Today Daiichi Sankyo News Today JCR Pharmaceuticals News Today Kyowa Kirin News Today Mayne Pharma Group News Today Ono Pharmaceutical News Today Otsuka News Today Roche News Today Sanofi News Today Virbac News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:CMOPF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmo Pharmaceuticals Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
